Skip to main content

research_and_development

SlimSEB Ingredient Cuts Glucose Spike 16.9% in Clinical Trial

SlimSEB Ingredient Cuts Glucose Spike 16.9% in Clinical Trial

Chino, Calif. – September 13, 2026 -- Specialty Enzymes & Probiotics has published dual-track research showing its ingredient SlimSEBTM reduces post-meal blood sugar spikes by 16.90% in a controlled human clinical trial, providing formulators with clinically backed data for glucose-support supplements.

Clinical trial confirms 16.90% reduction in glucose AUC

In a double-blind, randomized, placebo-controlled crossover trial, subjects supplemented with SlimSEBTM showed a 16.90% reduction in Area Under the Curve (AUC), a standard measure of post-prandial glycemic response. The result demonstrates statistically significant improvement in blood sugar control following meals.

Natural Field Launches NF TriSolve SleepRestore Complex

Natural Field Launches NF TriSolve SleepRestore Complex

Shanghai – September 11, 2026 -- Natural Field has expanded its NF TriSolve® branded nutraceutical solution platform into the sleep wellness category with the launch of NF TriSolve® SleepRestore Complex, targeting global nutrition brands seeking differentiated formulations.

Natural Field enters sleep wellness market with coordinated multi-ingredient formulation

The new SleepRestore Complex combines multiple functional components into a single coordinated concept designed specifically for sleep-focused nutraceutical applications. The launch marks Natural Field's push beyond its existing categories into the growing sleep wellness segment, following a solution-oriented innovation model rather than single-ingredient development.